Medindia

X

US Food And Drug Administration Approves GSK's Drug For Severe Asthma

by Shirley Johanna on  November 5, 2015 at 5:37 PM Drug News   - G J E 4
The US Food and Drug Administration approved an injectable drug, Nucala from GlaxoSmithKline to treat severe asthma attacks.

The drug has been approved to treat patients 12 years and older who cannot control their asthma with more conventional drug options.
US Food And Drug Administration Approves GSK's Drug For Severe Asthma
US Food And Drug Administration Approves GSK's Drug For Severe Asthma
Advertisement

Nucala will be administered once every four weeks by subcutaneous injection into the upper arm, thigh, or abdomen.

‘Nucala, an injected drug to treat severe asthma attacks has been approved by the US Food and Drug Administration. However, this drug has side effects like headache, injection site reactions, back pain, and fatigue.’
Advertisement
Nucala is a genetically engineered antibody is grown in cells from Chinese hamsters. The drug reduces severe asthma attacks by reducing the levels of white blood cells that contribute to the development of asthma.

Patients are advised to take other medications, including high-dose inhaled corticosteroids and at least one additional asthma drug.

The side effects of the drug include headache, injection site reactions, back pain, and fatigue. Hypersensitivity reactions can occur within hours or days of injection with Nucala.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All